Published in Acta Med Scand on October 01, 1975
Prevalence of primary and secondary hypertension: studies in a random population sample. Br Med J (1976) 2.57
The interaction of cigarette smoking, oral contraceptive use, and cardiovascular risk factor variables in children: the Bogalusa Heart Study. Am J Public Health (1982) 1.65
The prevalence of hypertension, obesity and dyslipidemia in individuals of over 30 years of age belonging to minorities from the pasture area of Xinjiang. BMC Public Health (2010) 1.16
Blood pressure and smoking: observations on a national cohort. Arch Dis Child (1995) 1.14
Effect of Smoking on Blood Pressure and Resting Heart Rate: A Mendelian Randomization Meta-Analysis in the CARTA Consortium. Circ Cardiovasc Genet (2015) 0.82
Life style as a blood pressure determinant. J R Soc Med (1996) 0.77
Parametric mediational g-formula approach to mediation analysis with time-varying exposures, mediators, and confounders. Epidemiology (2016) 0.75
Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J (2003) 17.80
European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr (2002) 8.77
Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) (1984) 5.79
Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA (2005) 5.60
Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial. Lancet (1981) 4.75
Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med (1984) 4.51
Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results. Lancet (1974) 4.40
The influence of body fat distribution on the incidence of diabetes mellitus. 13.5 years of follow-up of the participants in the study of men born in 1913. Diabetes (1985) 4.23
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Coronary heart-disease after treatment of hypertension. Lancet (1978) 3.78
Smoking and myocardial infarction. Lancet (1975) 3.42
Cardiac and pulmonary causes of dyspnoea--validation of a scoring test for clinical-epidemiological use: the Study of Men Born in 1913. Eur Heart J (1987) 3.15
Multivariate analysis of risk factors for coronary heart disease. Circulation (1973) 3.04
Hormones regulating cardiovascular function in patients with severe congestive heart failure and their relation to mortality. CONSENSUS Trial Study Group. Circulation (1990) 2.89
The Malmö Diet and Cancer Study: representativity, cancer incidence and mortality in participants and non-participants. Eur J Cancer Prev (2001) 2.72
Bias due to non-participation and heterogenous sub-groups in population surveys. J Chronic Dis (1983) 2.62
Beta-blockers versus diuretics in hypertensive men: main results from the HAPPHY trial. J Hypertens (1987) 2.59
Prevalence of primary and secondary hypertension: studies in a random population sample. Br Med J (1976) 2.57
Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S) Circulation (1998) 2.40
Prospective study of social influences on mortality. The study of men born in 1913 and 1923. Lancet (1985) 2.26
Overweight, obesity and fat distribution in 50- to 64-year-old participants in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr (2002) 2.25
Cholesterol lowering and the use of healthcare resources. Results of the Scandinavian Simvastatin Survival Study. Circulation (1996) 2.23
Registration of myocardial infarction in the city of Göteborg, Sweden. J Chronic Dis (1975) 2.20
Body weight and weight gain during adult life in men in relation to coronary heart disease and mortality. A prospective population study. Eur Heart J (1999) 2.16
Analysis of risk factors for stroke in a cohort of men born in 1913. N Engl J Med (1987) 2.08
Incident coronary events and case fatality in relation to common carotid intima-media thickness. J Intern Med (2005) 1.94
Risk factors for myocardial infarction and death due to ischemic heart disease and other causes. Am J Cardiol (1975) 1.94
A primary preventive study of Gothenburg, Sweden. Prev Med (1972) 1.92
Cessation of smoking after myocardial infarction. Effects on mortality after 10 years. Br Heart J (1983) 1.90
Primary prevention with metoprolol in patients with hypertension. Mortality results from the MAPHY study. JAMA (1988) 1.87
The multifactor primary prevention trial in Göteborg, Sweden. Eur Heart J (1986) 1.85
A comparison between participants and non-participants in a primary preventive trial. J Chronic Dis (1976) 1.80
Family burden of cardiovascular mortality: risk implications for offspring in a national register linkage study based upon the Malmö Preventive Project. J Intern Med (2004) 1.79
Smoking and abdominal obesity: risk factors for venous thromboembolism among middle-aged men: "the study of men born in 1913". Arch Intern Med (1999) 1.76
Prevalence and management of hypertension in a general population sample of Swedish men. Prev Med (1973) 1.76
Physical activity protects against coronary death and deaths from all causes in middle-aged men. Evidence from a 20-year follow-up of the primary prevention study in Göteborg. Ann Epidemiol (1997) 1.75
Psychosocial factors and venous thromboembolism: a long-term follow-up study of Swedish men. J Thromb Haemost (2007) 1.74
Beta-blockers and antithrombotic treatment for secondary prevention after acute myocardial infarction. Towards an understanding of factors influencing clinical practice. The European Secondary Prevention Study Group. Eur Heart J (1998) 1.73
Sociodemographic factors associated with long-term weight gain, current body fatness and central adiposity in Swedish women. Int J Obes Relat Metab Disord (2000) 1.72
Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study. Arch Intern Med (1996) 1.68
Population-attributable risk of coronary heart disease risk factors during long-term follow-up: the Malmö Preventive Project. J Intern Med (2006) 1.68
Geographic distribution of stroke incidence within an urban population: relations to socioeconomic circumstances and prevalence of cardiovascular risk factors. Stroke (2001) 1.67
Is abdominal body fat distribution a major explanation for the sex difference in the incidence of myocardial infarction? The study of men born in 1913 and the study of women, Göteborg, Sweden. Am J Epidemiol (1992) 1.66
Stressful life events, social support, and mortality in men born in 1933. BMJ (1993) 1.66
Insulin resistance in non-diabetic subjects is associated with increased incidence of myocardial infarction and death. Diabet Med (2002) 1.65
Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study. J Intern Med (2003) 1.64
Survival in treated hypertension: follow up study after two decades. BMJ (1998) 1.64
Self-perceived psychological stress and incidence of coronary artery disease in middle-aged men. Am J Cardiol (1991) 1.63
Coronary heart disease, cancer and mortality in male middle-aged light smokers. J Intern Med (1992) 1.62
Assessing the effect of interaction between an FTO variant (rs9939609) and physical activity on obesity in 15,925 Swedish and 2,511 Finnish adults. Diabetologia (2009) 1.62
Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness: Main results from the Beta-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS). Circulation (2001) 1.62
Impact of cardiovascular risk factors on coronary heart disease and mortality among middle aged diabetic men: a general population study. BMJ (1989) 1.61
Incidence of stroke is related to carotid IMT even in the absence of plaque. Atherosclerosis (2004) 1.60
Risk factors for stroke in middle-aged men in Göteborg, Sweden. Stroke (1990) 1.59
Relation between insulin resistance and carotid intima-media thickness and stenosis in non-diabetic subjects. Results from a cross-sectional study in Malmö, Sweden. Diabet Med (2000) 1.58
Lack of social support and incidence of coronary heart disease in middle-aged Swedish men. Psychosom Med (1993) 1.57
Cholesterol and total mortality: need for larger trials. BMJ (1992) 1.57
Plasma levels of complement C3 is associated with development of hypertension: a longitudinal cohort study. J Hum Hypertens (2006) 1.55
Diabetes mellitus and raised serum triglyceride concentration in treated hypertension--are they of prognostic importance? Observational study. BMJ (1996) 1.54
Risk factors for type 2 (non-insulin-dependent) diabetes mellitus. Thirteen and one-half years of follow-up of the participants in a study of Swedish men born in 1913. Diabetologia (1988) 1.53
Coronary heart disease and mortality in middle aged men from different occupational classes in Sweden. BMJ (1988) 1.53
Diastolic blood pressure and area of residence: multilevel versus ecological analysis of social inequity. J Epidemiol Community Health (2001) 1.52
Influence of obesity on cardiovascular risk. Twenty-three-year follow-up of 22,025 men from an urban Swedish population. Int J Obes Relat Metab Disord (2002) 1.52
Food patterns and components of the metabolic syndrome in men and women: a cross-sectional study within the Malmö Diet and Cancer cohort. Am J Epidemiol (2001) 1.51
Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men. BMJ (1990) 1.50
Ultrasound measurement of wall thickness in the carotid artery: fundamental principles and description of a computerized analysing system. Clin Physiol (1991) 1.50
Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). 1994. Atheroscler Suppl (2004) 1.50
Optimal risk factors in the population: prognosis, prevalence, and secular trends; data from Göteborg population studies. Eur Heart J (2001) 1.49
Socioeconomic differences in smoking cessation: the role of social participation. Scand J Public Health (2000) 1.47
Risk factors for heart failure in the general population: the study of men born in 1913. Eur Heart J (1989) 1.47
Control of blood pressure and risk of first acute myocardial infarction: Skaraborg hypertension project. BMJ (1994) 1.46
Organization and efficacy of an out-patient hypertension clinic. Acta Med Scand (1978) 1.45
Use of coronary angiography and revascularization procedures following acute myocardial infarction. A European perspective. Eur Heart J (1998) 1.45
Risk factors for fragility fracture in middle age. A prospective population-based study of 33,000 men and women. Osteoporos Int (2006) 1.44
Long-term weight change and breast cancer risk: the European prospective investigation into cancer and nutrition (EPIC). Br J Cancer (2005) 1.44
Follow-up study of patients randomized in the Scandinavian simvastatin survival study (4S) of cholesterol lowering. Am J Cardiol (2000) 1.43
Differences in the treatment of coronary heart disease between countries as revealed in the Scandinavian Simvastatin Survival Study (4S) Eur Heart J (1998) 1.42
Fatalities from myocardial infarction in Nordic countries and Lithuania. The MONICA Investigators. Eur Heart J (1997) 1.42
Improved long-term prognosis after myocardial infarction 1984-1991. Eur Heart J (1998) 1.42
Does treated primary hypertension lead to end-stage renal disease? A 20-year follow-up of the Primary Prevention Study in Göteborg, Sweden. Nephrol Dial Transplant (1998) 1.39
Increased systemic and renal vascular sensitivity to angiotensin II in normotensive men with positive family histories of hypertension. Am J Hypertens (1992) 1.39
Blunted renal sodium excretion during acute saline loading in normotensive men with positive family histories of hypertension. Am J Hypertens (1991) 1.39
Prediction of cardiovascular deaths and non-fatal reinfarctions after myocardial infarction. Acta Med Scand (1977) 1.38
Animal foods, protein, calcium and prostate cancer risk: the European Prospective Investigation into Cancer and Nutrition. Br J Cancer (2008) 1.38
Ketanserin, a novel 5-hydroxytryptamine antagonist: monotherapy in essential hypertension. Br J Clin Pharmacol (1983) 1.35
Independent importance of psychosocial factors for prognosis after myocardial infarction. J Intern Med (2000) 1.35
Low systolic blood pressure and self perceived wellbeing in middle aged men. BMJ (1993) 1.32
Stroke trends in the WHO MONICA project. Stroke (1997) 1.30